Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride 0.5mg was found to be more effective than finasteride 1mg in treating male pattern hair loss, with similar side effects.

Dutasteride 0.5mg is more effective than finasteride 1mg for treating male pattern baldness.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

Use minoxidil for hair loss treatment; assess results after 6 months.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Finasteride and minoxidil work best together for hair loss.

Hair loss treatments work better with lifestyle changes.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Mesotherapy shows promise for cellulite and facial rejuvenation but has mixed results for body sculpting and hair loss, with more research needed for safety and effectiveness.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Finasteride shows promise for female hair loss, but more research needed.

Chitosan-coated nanoparticles improve skin delivery of hair loss treatments with fewer side effects.

5-alpha reductase inhibitors are generally safe but can cause sexual side effects and require patient education on risks.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Rats had lasting erectile problems after stopping a certain medication.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.